O'Keefe Kenneth W 4
4 · Jazz Pharmaceuticals plc · Filed Aug 11, 2025
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Tax Payment
Ordinary Shares
2025-08-08$111.25/sh−1,805$200,807→ 28,672 total - Award
Ordinary Shares
2025-08-07+3,507→ 30,477 total
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.